Lenvaxen 10mg capsule

Lenvaxen 10 mg is an oral prescription medicine that consists of Lenvaxen 10 mg (Lenvatinib) Capsule | Thyroid Cancer Therapy (levatinib mesylate), made by Everest Pharmaceuticals. This drug is an oral multiple kinase inhibitor that helps to inhibit tumors from growing as well as prevent the formation LENVAXEN 10MG CAPSULE of new blood vessels that cancer cells need.

For the treatment of progressive, locally advanced, or metastatic disease resistant to radioactive iodine therapy. HCC: As a first-line therapy for nonresectable liver cancer. RCC: In combination with evero limus for advanced renal cell carcinoma.Endometrial Carcinoma: In combination with pembrolizumab for selected forms of the condition.

Active Ingredient: Lenvatinib Mesylate equivalent to 10 mg of Lenvatinib. Presentation: Capsules for oral use available in bottles of 30 capsules.

Dosage: Prescribed precisely by an oncologist according to the particular type of cancer and sometimes taking into account body weight in case of HCC. Taking: Swallow the capsule whole with water once per day at the same time, regardless of meals. Do not crush or chew.

Lenvaxen 10MG CAPSULE IN PAKISTAN is an oral prescription-targeted cancer drug (an inhibitor of kinases) intended for the treatment of advanced thyroid, renal cell, hepatocellular, and endometrial carcinoma. This medicine acts by inhibiting certain proteins that lead to the development of tumor blood vessel growth and proliferation of cancer cells.